Chi‐Chuan Wang

1.2k total citations
73 papers, 821 citations indexed

About

Chi‐Chuan Wang is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Chi‐Chuan Wang has authored 73 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 19 papers in Epidemiology and 13 papers in Economics and Econometrics. Recurrent topics in Chi‐Chuan Wang's work include Atrial Fibrillation Management and Outcomes (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical Practices and Patient Outcomes (8 papers). Chi‐Chuan Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical Practices and Patient Outcomes (8 papers). Chi‐Chuan Wang collaborates with scholars based in Taiwan, United States and United Kingdom. Chi‐Chuan Wang's co-authors include Chung‐Hsuen Wu, Jae Kennedy, Fang‐Ju Lin, Joel F. Farley, Shin‐Yi Lin, Shu‐Wen Lin, Wan‐Ting Huang, Huang‐Tz Ou, Matthew L. Maciejewski and Wang‐Huei Sheng and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Chi‐Chuan Wang

64 papers receiving 803 citations

Peers

Countries citing papers authored by Chi‐Chuan Wang

Since Specialization

Citations

This map shows the geographic impact of Chi‐Chuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chuan Wang more than expected).

Fields of papers citing papers by Chi‐Chuan Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Chuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chuan Wang. The network helps show where Chi‐Chuan Wang may publish in the future.

Co-authorship network of co-authors of Chi‐Chuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Chuan Wang. A scholar is included among the top collaborators of Chi‐Chuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Chuan Wang. Chi‐Chuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older 2025 ·BMC Geriatrics ·(unknown), (unknown), Chi‐Chuan Wang, Chin‐Chung Wu, Fang‐Ju Lin	1
2	Charting the path to better diabetes outcomes: Revealing psychosocial influences on medication adherence through the information-motivation-behavioral skills model among adults with type 2 diabetes 2025 ·Research in Social and Administrative Pharmacy ·(unknown), Hsun‐Yu Chan, Yunn‐Fang Ho, Hsiang‐Wen Lin, Chi‐Chuan Wang, (unknown), Yen‐Ming Huang	0
3	Outcomes of Reinitiating Direct Oral Anticoagulants After Intracranial Hemorrhage 2025 ·JACC Asia ·(unknown), Shin‐Yi Lin, Fang‐Ju Lin, Sung‐Chun Tang, Chi‐Chuan Wang	1
4	Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms 2024 ·Journal of the Formosan Medical Association ·Chih‐Fen Huang, (unknown), Fang‐Ju Lin, Chi‐Chuan Wang, Churn‐Shiouh Gau, Li‐Jiuan Shen	0
5	Associations of early adverse events with clinical outcomes in patients with NSCLC treated with EGFR tyrosine kinase inhibitors. 2024 ·Journal of Clinical Oncology ·Fang‐Ju Lin, (unknown), Chi‐Chuan Wang, Jin-Yuan Shih	1
6	Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome 2024 ·Journal of Thrombosis and Thrombolysis ·(unknown), Chien‐Chih Wu, Hsin‐Yi Huang, Chi-Yun Wu, Ching‐Chang Huang, Chi‐Chuan Wang	0
7	Predicting outcomes after hospitalisation for COPD exacerbation using machine learning 2024 ·ERJ Open Research ·Chih‐Ying Wu, Chien‐Ning Hsu, Charlotte Wang, Jung‐Yien Chien, Chi‐Chuan Wang, Fang‐Ju Lin	0
8	Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017 2023 ·Journal of the Formosan Medical Association ·(unknown), Fang‐Ju Lin, Chien‐Ning Hsu, Susan Shur‐Fen Gau, Chi‐Chuan Wang	2
9	Impact of an integrated medication management model on the collaborative working relationship among healthcare professionals in a hospital: an explanatory mixed methods study 2023 ·Journal of Interprofessional Care ·(unknown), Yen‐Ming Huang, Chih‐Fen Huang, Wang‐Huei Sheng, (unknown), Li‐Jiuan Shen, Chi‐Chuan Wang	0
10	Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study 2023 ·Hypertension Research ·Shin‐Yi Lin, Hsin‐Yi Huang, (unknown), (unknown), Chi‐Chuan Wang	5
11	Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke 2022 ·Mayo Clinic Proceedings ·Hsin‐Yi Huang, Shin‐Yi Lin, Aaron J. Katz, Jau-Jiuan Sheu, Fang‐Ju Lin, Chi‐Chuan Wang, Chung‐Hsuen Wu	6
12	Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan 2022 ·Frontiers in Pharmacology ·Chien‐Ning Hsu, (unknown), Fang‐Ju Lin, Huang‐Tz Ou, (unknown), (unknown), Chi‐Chuan Wang, Sengwee Toh	6
13	Impact of integrated medication management program on medication errors in a medical center: an interrupted time series study 2022 ·BMC Health Services Research ·(unknown), (unknown), Wang‐Huei Sheng, (unknown), Chi‐Chuan Wang, Li‐Jiuan Shen	2
14	Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study 2021 ·Cardiovascular Diabetology ·Fang‐Ju Lin, Chi‐Chuan Wang, Chien‐Ning Hsu, Chenyi Yang, Chih‐Yuan Wang, Huang‐Tz Ou	16
15	<p>Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study</p> 2019 ·Infection and Drug Resistance ·Chien‐Chih Wu, (unknown), (unknown), Chi‐Chuan Wang, Ching‐Hua Kuo, Shu‐Wen Lin, Shih‐Chi Ku	30
16	Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly 2018 ·Vaccine ·(unknown), Li‐Jiuan Shen, Yee‐Chun Chen, Jung‐Hsin Lin, Chi‐Chuan Wang	7
17	Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria 2017 ·Kidney & Blood Pressure Research ·(unknown), Fang‐Ju Lin, Huang‐Tz Ou, (unknown), Chi‐Chuan Wang	34
18	Alternative Therapies as a Substitute for Costly Prescription Medications: Results from the 2011 National Health Interview Survey 2015 ·Clinical Therapeutics ·Chi‐Chuan Wang, Jae Kennedy, Chung‐Hsuen Wu	5
19	National trends of psychotropic medication use among patients diagnosed with anxiety disorders: Results from Medical Expenditure Panel Survey 2004–2009 2013 ·Journal of Anxiety Disorders ·Chung‐Hsuen Wu, Chi‐Chuan Wang, Aaron J. Katz, Joel F. Farley	25
20	Examining the Relationship Between Adjunctive Psychotherapy Use and Antipsychotic Persistence and Hospitalization 2013 ·Administration and Policy in Mental Health and Mental Health Services Research ·Chi‐Chuan Wang, Matthew L. Maciejewski, Jaya K. Rao, Brian Sheitman, Betsy Sleath, Joel F. Farley	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact